Key points are not available for this paper at this time.
Interview with Kushal Kadakia on the 21st Century Cures Act, Cures 2.0, and lessons from Covid-19 for medical product development. (11:29)Download Notwithstanding ongoing confusion over the concepts of “real-world data” and “real-world evidence” in 2022, more than 5 years after the passage of the 21st Century Cures Act, the FDA continues to evaluate such data and evidence as it considers regulatory decisions.
Concato et al. (Sat,) studied this question.